MISSIONPHARMA GROUP ApS: Financial statements 2022
CVR: 29782792
Source: annual report 2022, Danish Business Authority
01/04/2021 – 31/03/2022
MISSIONPHARMA GROUP ApS (CVR 29782792) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -51,000 and a net result of DKK 52,312,000 compared with DKK 78,041,000 the year before. Equity in the 2022 report amounted to DKK 322,934,000. The solvency ratio was 98.1%. The company had 142 employees in the financial year.
- Revenue
- DKK 0
- Gross Profit
- DKK -51,000
- Profit/Loss
- DKK 52,312,000
- Equity
- DKK 322,934,000
- Total Assets
- DKK 329,049,000
- Employees
- 142
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 0 | -51 t. | 52.3 mio. | 322.9 mio. | 142 |
| 2021 | 0 | -66 t. | 78 mio. | 348.2 mio. | 150 |
| 2020 | 0 | -51 t. | 16.9 mio. | 284.8 mio. | 169 |
| 2019 | 0 | -60 t. | 32.9 mio. | 296.9 mio. | 174 |
| 2017 | 0 | -2 t. | 70.1 mio. | 318.5 mio. | 157 |
Official annual report
Keep an eye on MISSIONPHARMA GROUP ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of June 29, 2022, Forvis Mazars Statsautoriseret Revisionspartnerselskab has been appointed auditor of MISSIONPHARMA GROUP ApS.
As of June 29, 2022, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of MISSIONPHARMA GROUP ApS.
About MISSIONPHARMA GROUP ApS
MISSIONPHARMA GROUP ApS was a Danish company of the type Anpartsselskab based in Lynge, founded in 2006. The company has been dissolved on 15 December 2023. The company was registered under the industry Ikke-finansielle holdingselskaber. The company was previously named MIFAMED HOLDING ApS and MISSIONPHARMA HOLDING ApS. According to the 2023 annual report, the company had an average of 150 employees. In 2023, the company reported a gross profit of DKK -110,000 and a net result of DKK 118,139,000 compared with DKK 52,312,000 the year before. Equity in the 2023 report amounted to DKK 349,722,000.